【The Motley Fool】谷歌跌到15倍 是便宜还是陷阱

【The Motley Fool】谷歌跌到15倍 是便宜还是陷阱 — 浑水摸鱼清源

浑水摸鱼清源

AI-assisted summary of 【The Motley Fool】谷歌跌到15倍 是便宜还是陷阱 — original source. Check the original for full context.

Source published:

Key ideas

  • Alphabet(GOOGL)股价回落至290美元附近,往绩市盈率仅15至16倍,市场因其单季超500亿美元的AI资本开支引发现金流恐慌,但其年化营收达5000亿美元且保持20%至25%的增速,云业务积压订单达5610亿美元。 (15:00)
  • 布鲁克菲尔德(BN)管理层公开测算每股内在价值约为67美元,而当前股价约42美元,存在超35%的折价;其商业地产业务受高利率压制,但长期年化复合回报率达15%。 (20:00)
  • 面对Ouster和Twist Bioscience等短期暴涨数倍的持仓,专家提出四问评估框架:检视逻辑是否完好、仓位是否影响睡眠、无持仓是否仍愿买入,以及减仓带来的应税账户资本利得税负担。 (10:00)
  • 现金流折现(DCF)模型中终点价值通常占总估值的60%到80%,微小的折现率或长期增速调整会导致测算结果剧烈变动,内在价值应被视作动态区间而非精确点位。 (5:40)

Detailed notes

## Background 该视频由B站UP主“浑水摸鱼清源”于2026年11月17日发布,内容源自《The Motley Fool Hidden Gems Investing》播客节目。视频简介围绕“谷歌跌到15倍是便宜还是陷阱”展开,探讨了内在价值的计算逻辑、暴涨十倍股票的卖出标准,并重点拆解了Alphabet(GOOGL)与布鲁克菲尔德(BN)的投资价值与操作指引。

## TL;DR 节目首先通过洗衣店与出租房的通俗类比,阐明内在价值是企业全生命周期现金流折现的本质,指出终点价值在估值中权重过高因而必须以“估值区间”而非精确数字来看待。针对听众手中Ouster和Twist Bioscience等短期暴涨数倍股票的去留困惑,嘉宾提出了涵盖商业逻辑、仓位压力、重购意愿及税负冲击的四问决策框架,强调不宜单因估值高就草率全卖。随后,分析师分别推荐了被市场按公用事业股定价但底层增长强劲的Alphabet,以及结构复杂、管理层自报每股内在价值约67美元且大幅折价的布鲁克菲尔德作为潜在低估标的。

## Atmosphere & style 整期节目洋溢着理性、从容且兼具实战色彩的价值投资研讨氛围。主持人与两位嘉宾的交流既有对DCF模型局限性的严肃拆解,又穿插着对“持仓涨十倍不知所措”这种幸福烦恼的幽默打趣。对话从抽象的金融概念自然过渡到个股实操,既不盲目唱多也不制造焦虑,传递出一种在市场狂热与恐慌之间保持清醒、重视安全边际与心理舒适度的稳健投资质感。

## Bulletin - [15:00](https://www.bilibili.com/video/BV1rVs368EwT?t=900s) Alphabet(GOOGL)股价回落至290美元附近,往绩市盈率仅15至16倍,市场因其单季超500亿美元的AI资本开支引发现金流恐慌,但其年化营收达5000亿美元且保持20%至25%的增速,云业务积压订单达5610亿美元。 - [20:00](https://www.bilibili.com/video/BV1rVs368EwT?t=1200s) 布鲁克菲尔德(BN)管理层公开测算每股内在价值约为67美元,而当前股价约42美元,存在超35%的折价;其商业地产业务受高利率压制,但长期年化复合回报率达15%。 - [10:00](https://www.bilibili.com/video/BV1rVs368EwT?t=600s) 面对Ouster和Twist Bioscience等短期暴涨数倍的持仓,专家提出四问评估框架:检视逻辑是否完好、仓位是否影响睡眠、无持仓是否仍愿买入,以及减仓带来的应税账户资本利得税负担。 - [05:40](https://www.bilibili.com/video/BV1rVs368EwT?t=340s) 现金流折现(DCF)模型中终点价值通常占总估值的60%到80%,微小的折现率或长期增速调整会导致测算结果剧烈变动,内在价值应被视作动态区间而非精确点位。

## Key takeaways - [00:00](https://www.bilibili.com/video/BV1rVs368EwT?t=0s) 内在价值关注企业生命周期内所能产生的全部自由现金流的现值,与基于历史成本的账面价值有本质区别。 - [03:45](https://www.bilibili.com/video/BV1rVs368EwT?t=225s) 机械公式无法替代主观定性分析,不同分析师对同一份财报算出不同内在价值,恰恰为独立投资者提供了超越共识的优势。 - [05:40](https://www.bilibili.com/video/BV1rVs368EwT?t=340s) DCF模型中的终点价值往往占据整体估值的60%至80%,长期预测误差极大,投资者应秉持认知谦逊并将内在价值视为区间。 - [10:00](https://www.bilibili.com/video/BV1rVs368EwT?t=600s) 单纯因为估值高企并非充分的卖出理由,优秀企业往往具备凭借持续增长消化高估值倍数的能力。 - [10:00](https://www.bilibili.com/video/BV1rVs368EwT?t=600s) 面对短期暴涨个股,需从商业逻辑完好度、持仓对睡眠的影响、现价买入意愿及应税账户税负四个维度综合权衡。 - [12:08](https://www.bilibili.com/video/BV1rVs368EwT?t=728s) 全盘清仓的触发条件应当非常苛刻:仅限于商业逻辑彻底破裂,或估值极端到完美执行也无法支撑的地步。 - [15:00](https://www.bilibili.com/video/BV1rVs368EwT?t=900s) Alphabet在科技七巨头中估值最低,15至16倍市盈率被市场按公用事业股定价,反映了市场对近两年5000亿美元AI资本开支的焦虑。 - [15:00](https://www.bilibili.com/video/BV1rVs368EwT?t=900s) Alphabet的单季大额资本开支虽短期压缩自由现金流,但放眼五年以上,这笔投入大概率会转化为下一阶段的高质量增长。 - [19:12](https://www.bilibili.com/video/BV1rVs368EwT?t=1152s) 布鲁克菲尔德(BN)结构庞大复杂,旗下持有BAM约75%股权及受高利率压制的商业地产,复杂性导致其出现显著市场折价。 - [20:00](https://www.bilibili.com/video/BV1rVs368EwT?t=1200s) 布鲁克菲尔德管理层自报每股内在价值约67美元,较现价42美元折价约37%,该数字更接近中性基准情形而非激进的牛市预测。 - [21:18](https://www.bilibili.com/video/BV1rVs368EwT?t=1278s) 构建内在价值区间需要对宏观变量(如10年期美债收益率在2%-3%或升至8%的情景)进行压力测试,以确保具备足够的安全边际。

## Detailed walkthrough ### [00:00](https://www.bilibili.com/video/BV1rVs368EwT?t=0s) Defining Intrinsic Value: The Great Equalizer and the Laundromat Analogy

Host Jon Quast opens the episode of *Motley Fool Hidden Gems Investing* alongside contributors Rachel Warren and Matt Frankel. Following listener enthusiasm from the previous week's discussion on Berkshire Hathaway, the team commits to a deep dive into intrinsic value before opening the mailbag and pitching individual stock ideas. Jon highlights Warren Buffett’s longstanding belief that intrinsic value is the only truly logical foundation for comparing vastly different businesses. Traditional valuation metrics vary drastically across sectors—investors evaluate banks on price-to-tangible-book, insurance companies on float and combined ratios, and tech firms on revenue multiples or price-to-earnings. Intrinsic value cuts through these discrepancies by serving as the ultimate equalizer.

```mermaid flowchart TD accTitle: Intrinsic Value vs Book Value Framework accDescr: Diagram contrasting backward-looking accounting book value with forward-looking discounted cash flow intrinsic value.

subgraph BV["Book Value (Accounting Snapshot)"] direction TB B1["Historical Cost Basis"] B2["Balance Sheet: Assets - Liabilities"] B3["Distorted by Real Estate/Depreciation"] end

subgraph IV["Intrinsic Value (Economic Reality)"] direction TB I1["Forecast Free Cash Flows (Years 1-10)"] I2["Discount Future Cash to Present Value"] I3["Estimate Terminal Value (Post-Window)"] I4["Divide Net PV by Total Shares"] end

BV -.->|"Fails to capture future cash"| IV ```

Rachel Warren provides the foundational definition of the concept, contrasting forward-looking economic value against static accounting measures. To make the theoretical concept tangible, she points to everyday small businesses:

> “So when we talk about intrinsic value, we're basically asking a simple question: What is this business actually worth based on the cash it can generate over its entire lifespan adjusted for time and risk?”

She contrasts this with book value, which is merely a backward-looking accounting record of historical purchase prices minus liabilities. If an entrepreneur buys a neighborhood laundromat or a single-family rental property, they do not base their purchase price purely on what the washing machines or building materials originally cost. Instead, they examine the net cash remaining in their pocket each year after paying the water bill, local taxes, maintenance, and repairs, and then calculate what they are willing to pay today for that incoming stream of cash. In public equities, the exercise is identical: investors forecast future free cash flows, discount those dollars back to the present day—accounting for the fact that inflation and uncertainty mean a dollar a decade from now is worth less than a dollar today—and divide that total sum by outstanding shares to arrive at intrinsic value per share.

Matt Frankel emphasizes caution when mixing book value into intrinsic value estimates, especially within asset-heavy industries like commercial real estate. Under standard accounting principles, an office building purchased twenty years ago stays on the balance sheet at its historic depreciated cost, which may bear no resemblance to its true market value or cash-generating ability today. Consequently, an investor who knows how to look beyond surface-level accounting quirks can uncover overlooked businesses trading well below their genuine underlying worth.

- **Intrinsic Value vs. Book Value**: Book value is a backward-looking balance sheet snapshot; intrinsic value looks forward across the entire life of the company's cash generation. - **The Present Value of Money**: Future dollars must be discounted back to the present day to reflect inflation risk and opportunity cost. - **Accounting Discrepancies as Opportunities**: Static historical costs often obscure real estate or tangible asset values, creating mispricings for alert value investors.

---

[03:45](https://www.bilibili.com/video/BV1rVs368EwT?t=225s) Why Five Analysts Get Five Different Numbers: The Art vs. Science of DCF

The discussion shifts to the inherent ambiguity of intrinsic valuation. Jon Quast observes that Warren Buffett and his longtime partner Charlie Munger frequently examined identical corporate financials and yet emerged with completely different intrinsic value figures. For everyday investors who crave mathematical precision and clean scientific certainty, this subjectivity can feel deeply unsettling.

Matt Frankel responds that this absence of an immutable formula is not an analytical flaw, but rather an investor's greatest structural advantage:

> “Well, it's hard to nail down, and I apologize to anyone listening who is expecting a formula for intrinsic value because we can't do that.”

He points out that if five seasoned equity analysts attempt to model Berkshire Hathaway's intrinsic value, they will inevitably arrive at five distinct price targets. Because there is no single plug-and-chug equation, individual investors have the freedom to craft their own frameworks, building distinct bull-case and bear-case scenarios based on independent qualitative assessments. While textbook discounted cash flow (DCF) models quantify the concept by aggregating discounted future cash flows, Warren Buffett does not treat valuation as a rigid textbook exercise—if an off-the-shelf spreadsheet formula could determine true value, the broader market would immediately arbitrage away every opportunity. The real analytical edge lies in the nuanced, subjective judgment calls that algorithms and consensus models overlook.

- **Absence of a Universal Formula**: No single mechanical model dictates intrinsic value; analysts using identical inputs will reasonably differ. - **The Investor’s Edge**: Independent modeling allows individual investors to generate proprietary bull and bear scenarios that diverge from Wall Street consensus. - **Limits of Standard DCF**: Textbook discounted cash flow formulas cannot replace deep qualitative assessments of business moats and management acumen.

---

[05:40](https://www.bilibili.com/video/BV1rVs368EwT?t=340s) The Terminal Value Problem and Investor Humility

Jon Quast probes the practical tension between company lifespans and investor holding periods. Some historic businesses, such as footwear brand Birkenstock, have operated for roughly 250 years, yet individual retail investors typically manage portfolios on five- to ten-year horizons rather than holding across corporate centuries.

Rachel Warren explains that this disconnect creates the notorious "terminal value problem" in financial modeling:

> “Tweaks to a company's long term growth rate or discount rate that can really change your answer wildly.”

In a standard DCF model, an analyst forecasts granular cash flows for five to ten years and then appends a terminal value to capture everything the business will produce from that point into perpetuity. Because this terminal value often represents 60% to 80% of the entire calculated valuation, tiny adjustments to the assumed long-term terminal growth rate or discount rate can dramatically swing the output. For this reason, Rachel stresses that intrinsic value should never be treated as a single, precise number carved in stone, but rather as an evolving, thoughtful valuation range dictated by the perceived durability of the company's competitive moat.

Matt Frankel shares his deep skepticism of forecasting cash flows too far into the distance. Projecting a company's financial output in year fifteen is as speculative as predicting where an individual will be living and working fifteen years down the road. Unforeseen disruptions ensure that a corporate trajectory over a decade is never linear. Because terminal value calculations compound these subjective assumptions, Matt often bypasses heavy terminal value weighting, leaning instead on near-term cash generation and tangible Net Asset Value (NAV). The panel concludes that intellectual humility is one of the most underrated virtues in finance: an investor must maintain the conviction necessary to deploy capital while remaining honest about the massive uncertainties embedded in any long-range forecast.

- **The Terminal Value Distortion**: Minor tweaks of 0.5% in terminal growth or discount assumptions can swing intrinsic value outputs by dozens of percentage points. - **Valuation as a Range**: Intrinsic value is best viewed as a thoughtful range of probabilities rather than a rigid decimal point. - **The Long-Term Forecasting Fallacy**: Cash flow projections beyond 10 years carry exponential error rates, making near-term metrics and Net Asset Value (NAV) valuable anchor points. - **Humility as a Risk Tool**: Successful investing requires balancing the confidence to take a position against the humility to acknowledge unpredictable future variables.

---

[07:20](https://www.bilibili.com/video/BV1rVs368EwT?t=440s) Mailbag: When Valuations Stop Making Sense (Ouster & Twist Bioscience)

Jon introduces a question sent in by John from Denver, bringing the theoretical discussion of intrinsic value into practical portfolio management. While The Motley Fool teaches a long-term investment horizon of at least five years, real-world markets often introduce abrupt, disorienting price movements that test that patience.

John writes that he owned shares of lidar maker Ouster and synthetic biology firm Twist Bioscience. Following his purchase, both speculative growth holdings experienced sudden, massive price spikes that sent their share prices soaring before partially pulling back. Despite the partial correction, John found himself deeply conflicted because the underlying multiples had detached entirely from reality—the valuations simply stopped making any economic sense relative to their near-term business operations. Jon Quast emphasizes that almost every seasoned investor encounters this psychological dilemma: entering a stock at an attractive, reasonable valuation, only to watch euphoric market sentiment inflate the price to levels where the original thesis no longer squares with fundamental reality. This dilemma sets the stage for a systematic framework on how to handle sudden multi-bagger gains without violating long-term investing principles.

[10:00](https://www.bilibili.com/video/BV1rVs368EwT?t=600s) 暴涨十倍后的两难抉择:减仓、清仓还是拿住?

节目切入听众 John 提出的棘手问题:当手中持有的公司估值已经严重偏离基本面、“冲到雪橇前面”(out over their skis)时,投资者究竟该顺势减仓、大举止盈,还是咬牙继续拿住?主持人指出,John 提到了两只近期暴涨的股票:Ouster 和 Twist Bioscience。Ouster 是一家销售低成本激光雷达(LiDAR)的公司,三年前其股价对应的市销率(P/S)仅约 2 倍,而在今年早些时候一路飙升至将近 20 倍,估值在短期内翻了整整 10 倍;Twist Bioscience 的暴涨节奏则更快,年初估值约 4 倍市销率,到了年中直接冲上 28 倍市销率,短短数月估值暴涨了 7 倍。

面对这种看似幸福却极度折磨人的局面,Matt 笑着打趣说这实在是个“太棒的问题”,真希望自己投资组合里最大的烦恼也是“股票涨了 10 倍该怎么办”。但在严肃层面上,Matt 强调必须具体情况具体分析,并给出了他自己践行的四问决策框架:

```mermaid flowchart TD accTitle: 暴涨个股持有决策四步框架 accDescr: 面对估值脱轨的暴涨股票时,依次评估投资逻辑、仓位规模、现价买入意愿和税务后果四个维度。

subgraph Evaluation["核心评估维度"] Q1["1. 投资逻辑是否完好?<br/>(公司是否在按预期执行)"] Q2["2. 仓位占比有多大?<br/>(是否大到影响睡眠质量)"] Q3["3. 现价无持仓还会买吗?<br/>(从零审视当前风险收益比)"] Q4["4. 卖出会产生多大税负?<br/>(应税账户中的意外税单冲击)"] end

Q1 --> Decision["决策输出:持有 / 适度减仓 / 清仓"] Q2 --> Decision Q3 --> Decision Q4 --> Decision ```

在详细拆解这四个问题时,Matt 坦言,绝不能单纯因为涨得多就仓促卖出:

1. **投资逻辑是否完好**:公司是否依然在严格兑现你的预期?Matt 拿自己的切身教训举例,他当年过早卖掉了特斯拉,仅仅是因为觉得估值高了,而当时特斯拉完全在按照他的预期推进,因此“Valuation by itself is a weak reason to sell.”(Matt 强调,单纯因为估值高往往是极其薄弱的卖出理由)。 2. **仓位占比有多大**:这是决定是否减仓的关键所在。如果一只股票在组合中膨胀到令你寝食难安,适度减仓就是完全合理的,“Being able to sleep at night is worth more than the thought of a little bit more gain.”(Matt 提醒,夜夜安枕的价值远超过对再多赚一点利润的贪念)。如果是占组合 2% 的小仓位,大可放手让它跑;但若占比过重,减仓就是必须的风险控制。 3. **如果在今天这个价格,你还没持仓,你还会买吗**:将自己置于“局外人”的视角,是厘清究竟该卖、该减、该留还是该加仓的绝佳测试。 4. **应税账户的税务后果**:这往往是最容易被忽视的隐形成本。如果是在应税账户里涨了 10 倍的股票,哪怕仅仅减仓 25%,随后而来的巨额资本利得税单也可能会让你措手不及。

- **Ouster 估值狂飙**:从三年前的约 2 倍市销率涨至今年早些时候的接近 20 倍市销率,估值扩张达 10 倍。 - **Twist Bioscience 暴涨行情**:从年初约 4 倍市销率跳升至年中的 28 倍市销率,仅用数月就完成 7 倍的估值重估。

---

[12:08](https://www.bilibili.com/video/BV1rVs368EwT?t=728s) 内在价值视角:何时适度减仓,何时必须离场

主持人顺着话题指出,John 的案例固然极端,但现实中很多投资者在股票仅上涨 20% 或 30% 时就会喊着“估值看不懂了”想要止盈。这引出了一个深层矛盾:如果仅仅 20% 的涨幅就能让股价脱离合理估值,那么当初测算的内在价值到底算不算数?

Rachel 随后深入剖析了股价短期暴涨与内在价值之间的拉扯。她指出,长期投资绝不等于盲目无视估值,但传统估值指标之所以经常在伟大企业面前失灵,是因为市场已经在提前定价未来数年的高速成长。当一只股票暴涨、估值显得脱离现实时,核心考核标准应当是远期盈利潜力:“So in my mind, the key question to ask when a stock surges that way is not just, you know, has the share price gone up a lot? It's also, has the price outrun my most optimistic, reasonable estimate of what this business can earn five years from now?”(Rachel 强调,关键问题不是股价涨了多少,而是价格是否已经透支了对这家公司五年后盈利能力最乐观但合理的预估)。

Rachel 指出,真正具有颠覆性的超级企业往往具备“凭借自身成长消化高估值”的能力,并且屡屡能交出超预期的业绩答卷。因此,面对倍数高企的赢家,她通常不会选择全盘清仓,适度减持一小部分以平衡心理和仓位是明智的风控手段;但只要商业本质没有变坏,“letting the bulk of my shares ride through the volatility is often how you are able to capture a lot of the upside.”(Rachel 表示,让大部分仓位扛过波动,往往才是捕获巨大上行收益的必经之路)。她明确界定了彻底清仓的唯二红线:一是商业投资逻辑彻底破裂;二是估值已经狂飙到即便管理层未来执行得天衣无缝、挑不出一丝瑕疵,也完全无法支撑当前股价的地步。

- **适度减仓与清仓的界限**:因持仓占比过大导致失眠时,锁定小部分利润是合情合理的风险管理手段; - **全盘清仓的触发条件**:商业底层逻辑崩溃,或估值极端到“连完美执行都无法自圆其说”。

---

[15:00](https://www.bilibili.com/video/BV1rVs368EwT?t=900s) 谷歌被按公用事业股定价:2000亿资本开支是雷还是宝?

节目短暂插播互动环节后,进入重头戏——让嘉宾各自推荐一只既符合“隐形重磅”(Hidden Gems)特质、交易价格又明显低于其内在价值的标的。Rachel 出人意料地率先亮出了科技巨头 Alphabet(GOOGL),并坦承自己是其长期股东,利益高度攸关。

Alphabet 财报公布后股价回落到 290 美元区间,与 52 周高点拉开了显著差距。Rachel 指出,当前 Alphabet 的往绩市盈率(Trailing P/E)仅为 15 到 16 倍左右。然而,这是一家年化营收规模达到半万亿美元(5000 亿美元)的商业巨无霸,其顶线营收依然保持着同比约 20% 到 25% 的惊人增速。Rachel 犀利地反差对比道:现在的市场定价方式,简直是把它当成了一家增长缓慢、业务成熟的公用事业公司,而非全球顶级的科技复合增长引擎;在美股“科技七巨头”(Magnificent Seven)中,Alphabet 在往绩估值倍数上已经是最便宜的一家。

市场恐慌与估值折价的根源,完全集中在短期内向生成式 AI 狂砸资本开支(CapEx)所引发的焦虑上。Alphabet 仅单季度就砸下了超过 500 亿美元,在疯狂建设数据中心、大幅扩充自研 TPU 算力集群的过程中,甚至直接把自由现金流砸成了负数。但 Rachel 强调,剥离恐慌看底层引擎,基本面依然极其强悍: - **核心广告与生态**:即便对传统搜索变现采取保守预期,它依然掌握着全球无可撼动的数字广告底盘与庞大的 YouTube 流量生态; - **云业务爆发**:谷歌云(Google Cloud)营收实现翻倍以上增长,积压订单(backlog)规模高达 5610 亿美元。

面对主持人的追问——内在价值本质上是折现未来能拿回多少现金,而 Alphabet 今年资本开支达 2000 亿美元,明年可能冲到 3000 亿美元,两年砸出近半万亿美元,市场真正害怕的是这笔巨款能否加倍赚回——Rachel 坚定回应道,Alphabet 未来数年的发展动能恰恰孕育于如今的重金投入之中。未来几个季度自由现金流或许仍会受制压缩,“But looking ahead over the next five years and beyond, I think we see a really stark reversal there back to the type of growth that investors such as myself have become accustomed to from Alphabet.”(Rachel 坚信,放眼未来五年甚至更长时间,现金流将出现极其鲜明的反转,重新回到长期投资者所习以为常的高质量增长轨道)。

- **Alphabet 关键财务指标**: - 现价区间:290 美元左右(自 52 周高位明显回调); - 估值倍数:约 15 至 16 倍往绩市盈率(Trailing P/E); - 营收表现:年化营收约 5000 亿美元,同比增速约 20%~25%; - 资本开支:单季度支出逾 500 亿美元导致自由现金流一度转负,今年全年约 2000 亿美元,明年可能达 3000 亿美元; - 云计算实力:营收翻倍,积压订单(backlog)达 5610 亿美元。

---

[19:12](https://www.bilibili.com/video/BV1rVs368EwT?t=1152s) 布鲁克菲尔德登场:一家敢自报内在价值的复杂帝国

随后,话题转向 Matt 挑选的低于内在价值的标的——布鲁克菲尔德(Brookfield Corporation,代码:BN)。主持人评价道,选择布鲁克菲尔德非常应景,因为它是市场上极少数敢于主动在公开演示材料中直接向投资者测算并公布“自家股票每股内在价值估算”的奇特公司。

Matt 首先对这种官方测算打了一剂预防针。他告诫投资者,必须时刻牢记是谁在做这份估算:“When a company gives you an estimate of its own intrinsic value, remember who's making the estimate. It's the company. They're putting it in a presentation because they want to make their company look very valuable.”(Matt 提醒大家,当一家公司给你出具其内在价值评估时,要记住做评估的人就是公司自己;他们把数据写进幻灯片,初衷本就是为了让自家企业看起来价值连城)。因此必须带着天然的审慎态度去拆解。

紧接着,Matt 开始梳理布鲁克菲尔德异常庞大且复杂的业务版图。他笑称要把布鲁克菲尔德的全部底细讲透,整整录一期播客都不够。其基本盘主要由三大核心支柱交织而成: 1. **全球另类资产管理业务**:直接持有独立上市实体布鲁克菲尔德资产管理公司(Brookfield Asset Management,股票代码:BAM)约 75% 的绝对控股股权; 2. **快速扩张的保险业务**(Insurance solutions); 3. **庞大的房地产与实物资产组合**(Real estate assets)。正是这些交错纵深的资本架构,构成了后续评估其价值折价的核心拼图。

[20:00](https://www.bilibili.com/video/BV1rVs368EwT?t=1200s) Brookfield's Complex Structure and Management's $67 Valuation

Brookfield operates as a sprawling empire holding substantial stakes in numerous publicly traded subsidiaries and vehicles—such as Brookfield Infrastructure, among five or six distinct entities. While searching for Brookfield yields a dizzying array of related companies, this multifaceted structure makes it a notoriously complex business to analyze. That exact complexity, however, frequently creates favorable mispricings for savvy investors. Currently, commercial real estate assets—which constitute a major portion of Brookfield's holdings—are severely depressed because high interest rates have hammered property values.

```mermaid flowchart TD accTitle: Brookfield Valuation and Discount Overview accDescr: Diagram illustrating Brookfield's asset structure, management's intrinsic value estimate versus current market price, and long-term tailwinds. subgraph Assets["Brookfield Asset Footprint"] A["Commercial Real Estate (Beaten down by high interest rates)"] B["Publicly Traded Vehicles (Brookfield Infrastructure, etc.)"] C["Alternative Assets (High demand from AI build-out)"] end subgraph Valuation["Per-Share Valuation Gap"] D["Management Intrinsic Value: ~$67"] E["Current Market Price: ~$42"] D -->|"~37% Discount"| E end Assets --> Valuation ```

Unlike most public corporations, Brookfield's management explicitly publishes its own per-share intrinsic value calculation. Matt notes that whenever corporate management offers an internal valuation target, investors must approach it with healthy skepticism: “So if you look at management's value estimate, which when management does that, like I said, take it with a grain of salt.” However, their disclosure is uniquely useful because management breaks down their assumptions line by line, allowing outside investors to examine exactly where the numbers originate and dial back any overly rosy inputs. Management pegs Brookfield's intrinsic value at approximately $67 per share. Matt points out that CEO Bruce Flatt has spent more than two decades consistently getting the math right, earning him the benefit of the doubt. With the stock trading around $42 per share, the market offers a substantial discount against an asset manager that has compounded capital at approximately 15% annually over several decades, positioned right in front of surging institutional appetite for alternative assets driven by the global AI build-out.

- **Underlying holdings:** Large exposure to depressed commercial real estate alongside stakes in listed vehicles like Brookfield Infrastructure. - **Management per-share estimate:** ~$67 intrinsic value per share. - **Current market price:** ~$42 per share, representing an attractive discount of over 35%. - **Long-term track record:** CEO Bruce Flatt possesses a 20-year history of accurate capital allocation, compounding at ~15% annualized for decades.

[21:18](https://www.bilibili.com/video/BV1rVs368EwT?t=1278s) Why Intrinsic Value Needs a Range: Bull, Bear, and Base Cases

The host observes that while retail investors might celebrate hearing a clean intrinsic value figure of $67, legendary capital allocators like Warren Buffett famously avoid providing a single static number. Buffett preferred an intrinsic value range because a spectrum better captures the fluid economic variables underlying any business. When asked whether management's $67 figure is overly exact and what a realistic range looks like, Matt emphasizes that management’s point estimate is anchored to specific internal benchmarks—specifically their targets for corporate growth and their forward expectations for interest rates.

To calculate intrinsic value responsibly, an individual investor must stress-test those variables by constructing distinct bull, bear, and base cases. For instance, if yields on the 10-year U.S. Treasury drop back toward 2% or 3% over the next few years, Brookfield’s discounted cash flow profile and real estate valuation look radically different than in a scenario where the Federal Reserve hikes rates multiple times and pushes the 10-year Treasury yield up to 8%. Matt explains that Brookfield’s $67 internal estimate is not an aggressive or unrealistic bull case; rather, it reflects a balanced middle-of-the-road base case. As Matt puts it: “Theirs would be what I would call kind of more toward a middle or a base case. But having the bull and bear case really can help you form a range and know what you're paying for these assets if things don't work out perfectly.”

The show wraps up with the customary Motley Fool disclosures: contributors may hold financial interests in the equities discussed, and the network maintains formal recommendations that should prevent listeners from trading solely on audio commentary. All personal finance reporting adheres to strict editorial standards independent of advertiser approval. The host concludes by thanking producer Dan Boyd, Rachel, and Matt before signing off for the episode.

- **Sensitivity drivers:** Intrinsic valuation models fluctuate dramatically depending on macro benchmarks, such as whether 10-year Treasury yields trend toward 2%–3% or spike toward 8%. - **Nature of Brookfield's target:** The $67 figure functions as a reasonable base case rather than an extreme bull-market projection. - **Risk management rule:** Mapping bear and bull extremes ensures investors know their margin of safety when business conditions fail to unfold as planned.

## Notable quotes > [10:00](https://www.bilibili.com/video/BV1rVs368EwT?t=600s) Valuation by itself is a weak reason to sell. — Matt Frankel

> [10:00](https://www.bilibili.com/video/BV1rVs368EwT?t=600s) Being able to sleep at night is worth more than the thought of a little bit more gain. — Matt Frankel

> [00:00](https://www.bilibili.com/video/BV1rVs368EwT?t=0s) When we talk about intrinsic value, we're basically asking a simple question: What is this business actually worth based on the cash it can generate over its entire lifespan adjusted for time and risk? — Rachel Warren

> [19:12](https://www.bilibili.com/video/BV1rVs368EwT?t=1152s) When a company gives you an estimate of its own intrinsic value, remember who's making the estimate. It's the company. They're putting it in a presentation because they want to make their company look very valuable. — Matt Frankel

> [12:08](https://www.bilibili.com/video/BV1rVs368EwT?t=728s) letting the bulk of my shares ride through the volatility is often how you are able to capture a lot of the upside. — Rachel Warren

## Mentioned Alphabet, GOOGL, Brookfield Corporation, BN, Brookfield Asset Management, BAM, Brookfield Infrastructure, Ouster, Twist Bioscience, Berkshire Hathaway, Tesla, Birkenstock, Warren Buffett, Charlie Munger, Bruce Flatt, Jon Quast, Rachel Warren, Matt Frankel, Google Cloud, YouTube

## Video description 【The Motley Fool】 谷歌跌到15倍 是便宜还是陷阱 Spelling Out Intrinsic Value Using the Alphabet

|谷歌被当成公用事业股定价 Alphabet(GOOGL)财报后回落到290美元附近,明显低于52周高点,年化市盈率只有15到16倍。可它一年营收5000亿美元,收入还在以25%左右的速度增长。市场给它的估值更像一家增长缓慢的成熟公用事业公司,而不是科技巨头,在“七巨头”里它是最便宜的那个。便宜是真便宜,但便宜背后有没有原因,才是要弄清楚的。

|便宜的原因藏在资本开支里 今年资本开支2000亿美元,明年可能到3000亿美元,两年下来接近5000亿。内在价值的前提是这些钱未来不光要收回来,还得赚出利润。投资者真正担心的是:这么砸下去,能不能换来足够的现金回报。所以未来几个季度自由现金流可能继续被压缩,但把眼光放到5年以上,这笔投入大概率会换来增长重新加速。短期难看,长期才有戏。

|内在价值到底怎么算 内在价值问的是一件事:这家公司整个生命周期能生出多少现金,折算到今天值多少钱。它和账面价值不是一回事,账面价值是会计快照,看的是历史成本,内在价值看的是未来利润。把未来每年的自由现金流折现再加总,除以股本,就是每股内在价值。难点在于终点价值往往占整个测算的60%到80%,长期增速或折现率稍微动一下,结果就面目全非。

|五个分析师能给出五个答案 巴菲特和芒格看同一家公司、同一份数据,算出来的内在价值都能不一样。问五个分析师伯克希尔值多少钱,大概率得到五个答案。这不是缺陷,反而是优势——你自己定义、自己建模,就有了别人没有的判断。关键是要把它当成一个区间,而不是一个精确数字。看得越远越不准,预测第15年的现金流,跟预测自己15年后在干嘛差不多。

|涨了十倍该不该卖 有听众问,Ouster和Twist Bioscience买完暴涨,估值已经看不懂了,该做空、减仓还是拿着。Ouster三年前股价约等于两年营收,今年年初冲到年营收的近20倍;Twist年初约4倍年营收,年中飙到28倍,几个月涨了七倍。判断标准可以拆成四个问题,其中一个是:如果今天没持仓,这个价格我还买不买?另一个常被忽略:减仓会不会带来意外的税单。

|真正该走的时候 股价涨得凶,关键不是“涨了多少”,而是价格有没有超过你对这家公司5年后最乐观的合理估算。如果生意还在运转、还在拉客户、毛利还在扩、护城河还在加固,那让大部分仓位扛过波动,往往才是赚大钱的方式。只有商业逻辑崩了,或者估值极端到完美执行也撑不住股价,才考虑清仓。仓位大到影响睡眠,锁定一点利润也合理,但那是风险管理,不是择时。

|布鲁克菲尔德自己报了个价 布鲁克菲尔德(BN)是少数自己给投资者算内在价值的公司,管理层给出的每股内在价值约67美元,而股价约42美元,折价不小。它业务复杂:全球资管、保险、房地产,还持有布鲁克菲尔德资产管理(BAM)约75%的股权。商业地产因利率高企价值大跌,恰恰是这类复杂结构里容易挖到便宜货的地方。管理层测算要带着怀疑看,但CEO布鲁斯·弗拉特做了二十年,长期年化回报约15%,可信度不低。

接下来建议的操作指引: 1. Alphabet(GOOGL)现价290美元附近、市盈率15到16倍,盯未来几个季度自由现金流是否继续被2000亿资本开支压缩,等现金流拐点再谈加仓。 2. 布鲁克菲尔德(BN)股价约42美元、管理层给的每股内在价值约67美元,折价约37%,跟踪商业地产估值和利率走向,折价收窄到20%以内要重新评估。 3. 手里有短期暴涨十倍的票,先问“今天没持仓还买不买”,再算减仓25%的税单,商业逻辑没崩就别因为市盈率难看全砍。

[0:04] 内在价值概念开场与本期主题 [2:04] 用洗衣店和出租房讲清内在价值 [4:04] 巴菲特芒格算出不同答案 [6:06] 终点价值占测算六到八成 [9:07] 听众提问暴涨十倍该不该卖 [12:08] 减仓的四个判断问题 [16:10] 谷歌估值与5000亿资本开支 [19:12] 布鲁克菲尔德自报每股67美元 [21:12] 内在价值区间与管理层测算可信度

[Source](https://www.bilibili.com/video/BV1rVs368EwT)

中文简报

【The Motley Fool】谷歌估值降至15倍:是便宜机会还是价值陷阱? 节目首先通过洗衣店与出租房的通俗类比,阐明内在价值是企业全生命周期现金流折现的本质,指出终点价值在估值中权重过高,因而必须以“估值区间”而非精确数字来看待。针对听众手中Ouster和Twist Bioscience等短期暴涨数倍股票的去留困惑,嘉宾提出了涵盖商业逻辑、仓位压力、重购意愿及税负冲击的四问决策框架,强调不宜单因估值过高就草率清仓。随后,分析师分别推荐了被市场按公用事业股定价但底层增长强劲的Alphabet,以及业务架构复杂、管理层自报每股内在价值约67美元且呈大幅折价的布鲁克菲尔德作为潜在低估标的。 Alphabet(GOOGL)股价回落至290美元附近,往绩市盈率仅15至16倍;尽管市场对其单季超500亿美元的AI资本开支引发现金流恐慌,但其年化营收达5000亿美元且保持20%至25%的增速,云业务积压订单亦达5610亿美元。 (15:00) 布鲁克菲尔德(BN)管理层公开测算每股内在价值约为67美元,而当前股价约42美元,存在超35%的折价;其商业地产业务虽受高利率压制,但长期年化复合回报率仍达15%。 (20:00) 面对Ouster和Twist Bioscience等短期暴涨数倍的持仓,专家提出四问评估框架:检视核心逻辑是否完好、持仓比例是否影响睡眠、若无持仓是否仍愿买入,以及减仓给应税账户带来的资本利得税负担。 (10:00) 在现金流折现(DCF)模型中,终点价值通常占总估值的60%到80%,微小的折现率或长期增速假设调整均会导致测算结果剧烈变动,因此内在价值应被视作动态区间而非精确点位。 (5:40)

Reading summary

本期节目深入探讨了内在价值的评估框架,指出内在价值是立足未来现金流折现的动态区间而非死板公式,并针对个股估值暴涨后的操作抉择,以及 Alphabet 和布鲁克菲尔德(Brookfield)两只被市场低估标的的基本面与估值展开了详细剖析。 内在价值的本质与现金流折现局限 (0:00) Rachel Warren 指出,内在价值反映的是企业整个生命周期内所能产生的现金流经时间与风险调整后的现值,这与基于历史成本减负债的账面价值(Book Value)有着本质不同。账面价值常因历史折旧等会计规则而失真,无法体现商业地产或运营资产的真实造血能力。然而,以现金流折现(DCF)量化内在价值并非精密科学,微调长期终值(Terminal Value)增长率或折现率就会导致测算结果剧烈波动。正因终值往往占到估值的 60% 至 80%,Matt Frankel 强调对十至十五年后的长期预测保持怀疑与谦逊十分必要,建议将内在价值视为概率区间,或更多锚定于近期的现金流产生能力与净资产价值(NAV)。 估值脱轨暴涨时的四步决策框架 (10:00) 针对投资者在标的暴涨后(如 Ouster 市销率从约 2 倍升至近 20 倍、Twist Bioscience 市销率数月内从 4 倍冲上 28 倍)面临的止盈焦虑,Matt 提出了由四个问题构成的决策体系:一是投资逻辑是否依然完好,单凭估值偏高往往是脆弱的卖出理由;二是仓位占比是否大到影响睡眠,过度膨胀时适度止盈以控制风险十分合理;三是若现价无持仓是否仍愿意买入,以此从外部视角审视风险收益比;四是应税账户可能产生的资本利得税负担。Rachel 补充认为,具有颠覆性的超级企业常能凭借超预期增长消化高估值,只要商业本质未坏,留存大部分仓位往往是捕获巨大上行的关键,彻底清仓通常仅限于底层逻辑崩溃或估值脱节到即便未来执行完美也无法支撑的极端情况。 Alphabet:重金资本开支下的公用事业定价 (15:00) Rachel 推荐了 Alphabet 作为折价标的,其股价自 52 周高位回落至 290 美元左右,往绩市盈率仅约 15 至 16 倍,估值甚至落入公用事业股区间,成为科技七巨头中往绩估值最便宜的公司。市场的主要恐慌在于其对生成式 AI 的巨额资本开支,单季度投入逾 500 亿美元扩建数据中心与 TPU 算力集群,导致自由现金流一度转负,全年开支预计达 2000 亿美元,明年或冲至 3000 亿美元。但 Rachel 强调,Alphabet 年化营收约 5000 亿美元且保持 20% 至 25% 的增速,核心数字广告与 YouTube 生态依然稳固,谷歌云营收翻倍且积压订单达 5610 亿美元。她预期未来几季度现金流或受压制,但放眼五年以上,如今的重金投入将推动自由现金流实现强劲反转。 布鲁克菲尔德:复杂帝国的估值折价与敏感性 (19:12) Matt 挑选了旗下拥有另类资产管理(BAM 约 75% 股权)、保险及商业地产实物资产的布鲁克菲尔德(BN)。该集团因高利率重创商业地产价值以及跨多个上市实体的复杂架构,长期存在估值折价。管理层在其公开演示材料中自行测算的每股内在价值约为 67 美元,而当前市价约为 42 美元,折价幅度超 35%。虽然对企业自报的内在价值应保持审慎,但鉴于 CEO Bruce Flatt 拥有二十余年年化复合回报约 15% 的良好资本配置记录,且管理层给出了详细测算依据,该 67 美元更接近中性基准情景。Matt 提醒投资者需结合基准情景、牛市与熊市情景建立估值区间,特别是要对 10 年期美债收益率未来走向(如回落至 2%–3% 还是升至 8%)对折现率和资产价值的冲击进行压力测试。 本期节目展示了如何将内在价值作为一种动态的概率区间工具来评估投资机会与风险。无论面对 Alphabet 因短期资本开支激增引发的现金流焦虑,还是布鲁克菲尔德受宏观利率与资产重组影响的折价,评估核心都在于审视当前价格是否提供了足够的安全边际,并对长期预测中的不可知变量保持理性与敬畏。

精炼阅读摘要

The Motley Fool节目探讨了内在价值作为跨行业评估基石的逻辑,指出估值应是基于未来现金流折现的动态区间而非僵化公式;面对市场非理性波动与重金投入期,投资者需平衡长期盈利预期、持仓风控与宏观情景分析。 内在价值的核心逻辑与主观边界 (0:00) Rachel Warren与Matt Frankel指出,内在价值是比较不同行业商业价值的底层基准,它要求投资者预测企业生命周期内的自由现金流并折现至当下,而非依赖账面价值这一基于历史成本的静态会计指标。然而,现金流折现模型(DCF)并非确定性的公式,即便是巴菲特与芒格也会对同一家公司得出不同估算。终端价值(Terminal Value)通常占DCF计算总值的60%至80%,长期增长率或折现率哪怕仅有微调,都会导致结果大幅偏离。因此,内在价值本质上是一个动态的概率区间,面对超过十年的远期预测,投资者应保持智识上的谦逊,结合近期现金生成能力与有形净资产价值(NAV)进行锚定。 持仓非理性暴涨时的四维决策框架 (10:00) 针对个股估值严重脱离基本面的情况(如Ouster市销率从2倍暴增至近20倍、Twist Bioscience数月内从4倍冲上28倍),Matt提出了由四个问题构成的应对机制:一是商业投资逻辑是否完好推进,单纯因为估值高往往是最薄弱的卖出理由;二是仓位占比是否大到影响睡眠,过度集中时必须适度减仓以控制风险;三是若现价无持仓,自己是否仍有买入意愿;四是应税账户可能产生的资本利得税负担。Rachel补充表示,真正优质的企业能凭借后续成长消化倍数,只要基本面未坏,让大部分仓位承受波动是赚取巨大上行收益的关键;只有在底层逻辑破裂或估值即使在完美执行下也无法自圆其说时,才应触发清仓。 Alphabet:估值回落至公用事业水平的成长巨头 (15:00) Rachel推荐了股价回调至290美元区间的Alphabet,指出其往绩市盈率降至约15到16倍,在美股“科技七巨头”中估值最为低廉,市场定价几乎将其视作低增长的公用事业股。然而,该公司年化营收约达5000亿美元,顶线增速仍保持在20%至25%,核心搜索广告与YouTube流量盘坚挺,谷歌云营收实现翻倍且积压订单高达5610亿美元。当前市场恐慌主要源于激进的人工智能资本开支——单季度开支逾500亿美元导致自由现金流一度转负,今年全年开支约2000亿美元,明年可能达3000亿美元。Rachel认为,这笔巨额投入孕育着未来发展动能,尽管短期自由现金流承压,但放眼五年及以上维度,现金流有望迎来强劲反转。 Brookfield:复杂帝国折价与基准情景测算 (20:00) Matt分析了业务版图横跨另类资产管理、保险解决方案及庞大房地产资产的Brookfield。尽管高利率重创了商业地产估值并导致业务架构极其繁复,但也创造了被低估的套利空间。公司管理层在公开推介中主动披露了每股约67美元的内在价值估算,相较于其42美元左右的市场交易价格折价超过35%。Matt强调,对管理层自报的估值必须保持审慎,但CEO Bruce Flatt具备逾20年以约15%年化复合增长率配置资本的可靠记录。该67美元估值反映的是中性基准情景,投资者应通过压力测试构建不同情景:例如考量10年期美债收益率回落至2%至3%的乐观情况,或利率飙升至8%的悲观冲击,以明确在极端环境下的安全边际。 本期讨论表明,内在价值评估的核心在于通过审慎的主观假设抵御市场情绪干扰。无论是面对持股短期暴涨带来的心理煎熬,还是评估Alphabet高额资本开支或Brookfield复杂的折价架构,投资者都应借助基准、乐观与悲观的情景建模来测算安全边际,而非寄望于单一机械数字。

Source quotes

[10:00] Matt Frankel: Valuation by itself is a weak reason to sell. [10:00] Matt Frankel: Being able to sleep at night is worth more than the thought of a little bit more gain. [0:00] Rachel Warren: When we talk about intrinsic value, we're basically asking a simple question: What is this business actually worth based on the cash it can generate over its entire lifespan adjusted for time and risk? [19:12] Matt Frankel: When a company gives you an estimate of its own intrinsic value, remember who's making the estimate. It's the company. They're putting it in a presentation because they want to make their company look very valuable. [12:08] Rachel Warren: letting the bulk of my shares ride through the volatility is often how you are able to capture a lot of the upside.

Original transcript

[0:00] Spelling out intrinsic value using the alphabet, Motley Fool Hidden Gems Investing starts now. Welcome to Motley Fool Hidden Gems Investing. I'm your host today, Jon Quast, and I am joined by Foolish contributors Rachel Warren and Matt Frankel. On today's episode, we're going to go to the mailbag and we're also going to Let our guest Pitch a stock each to you, our listeners, But first I want to talk about intrinsic value. On last week's episode, we did briefly touch on this concept of intrinsic value. We teased maybe doing a full episode on it, and that was well-received by you, so thank you for that. And we're going to dive into that here today, talking about intrinsic value. Now, Last week, we did touch on the subject because we were talking about Berkshire Hathaway. Longtime Berkshire Hathaway CEO Warren Buffett was a person who really championed this concept of intrinsic value. And one of the things that he talked about was it's the only... logical way to compare businesses. If you are a value-minded investor, you know that sometimes we use different metrics for different classes of companies. We're going to value a bank one way, an insurance company one way, but maybe we're going to value a tech company another way. Intrinsic value is kind of this great equalizer here. And so it's really important. And that's why I'm going to kick it off here to Rachel first to just kind of walk us through from a theoretical dictionary way. What is intrinsic value? So when we talk about intrinsic value, we're basically asking a simple question. What is this business actually worth based on the cash it can generate over its entire lifespan adjusted for time and risk? That's very different from book value. Book value is more of an accounting snapshot of what a company owns today versus what it owes on its balance sheet. Book value looks backward at historical costs. sets. You could kind of give a concrete example for this. Imagine you buy a local laundromat or a rental property. You wouldn't just look at the price of the washing machines, the laundromat, for example. You'd look at how much cash is left over in your pocket every year after paying the water bill, after you pay the taxes, after you make repairs. And then you would decide how much you're willing to pay today for that stream of future cash. So with a public stock, intrinsic value works in a similar way. Investors estimate the free cash flow a company will count those future dollars back to what they're worth today, because a dollar 10 years from now is worth less than a dollar in your hand today. Inflation risk is part of the reason for that. And then when you add up that discounted cash flows and divide by the number of shares, you get an estimate of intrinsic value per share. Matt, is there anything that you would add to that definition? No, I mean, that's a good thing. But I would say be careful when you look at book value and how you incorporate it into intrinsic value, because for different industries, especially, there's a lot of accounting issues. Book value is an accounting number, period. Intrinsic value is what you want to find for the actual value of the company. So that's not a great dictionary definition. But book value, it's an accounting term that kind of like for real estate companies, which is a big area I follow, it tracks the amount that these companies paid for their properties. Now, if you bought an office building 20 years ago, The value of that office building today is not the same thing, but that's what's going to be reflected in your book value. So there are really good opportunities, and we can get to this later, to find companies that are trading below their intrinsic value and are overlooked because of these accounting issues that might make book value look different than it actually is. And so I hope that our listeners here are able to start understanding why this is such a powerful concept. Essentially, you're going to be able to understand what you're doing. with intrinsic value, you're able to say, here's what the business is actually worth. And so if you can figure out what the business is actually worth, and lo and behold, the stock price is below that price, then you're able to buy a company objectively for less than it's worth. Now, here's where the rubber meets the road. Warren Buffett saying that he and his long-term, right-hand man, Charlie Munger, would look at the same company, have the same data in front of them, and come up with different numbers of intrinsic value. And I think that if I'm an investor, I really want this to be a science. I want to nail this down. I don't like the ambiguity for something that seems like it could be so powerful. And so, Matt, why is this something that is hard to nail down precisely. Well, it's hard to nail down, and I apologize to anyone listening who is expecting a formula for intrinsic value because we can't do that. And if you asked five stock analysts... what Berkshire Hathaway's intrinsic value is, you're likely to get five different answers. But that's also what can make intrinsic value an investor's advantage, because you develop your own way of finding it, you develop your [5:00] own methods. And so that's really what why intrinsic value is such an important concept. You can make kind of different estimates of your intrinsic value on your own. You can make a bull case, a bear case, you know, for the same stock. You know, there are several different, you know, textbook methods. You know, the discount cash flow model is one that we could talk about, where the intrinsic value of a company is based on all of its future cash flows adjusted for the present value of money, This is going to sound like an economics 101 lesson. I don't want to put anyone to sleep, so I won't go into that too deep. So there are textbook methods. There are ways. Obviously, Buffett doesn't just use the discount cash flow model to the textbook because everyone else would be able to see where there is intrinsic value as well. So this is the kind of secret sauce a lot of investors have. are overlooking. So sorry, I'm not going to give you a formula for intrinsic value, but that again, that's also what makes it such a cool part of your investing toolkit. Rachel, I think that some people, some investors out there call foul on this concept because part of the definition of intrinsic value is all the future cash flows that a business can produce. And then you have some companies out there, I think Birkenstock, isn't that like a 200 year old company at this point? I mean, we're not going to invest for the lifetime. Yeah, we're not going to invest for the lifetime of Birkenstock. So it's like, well, I'm going to want to sell this stock someday. I don't want to hold it through the entire lifetime of the company. And so... Where does that fit into, I'm investing today and maybe I have a five to 10 year horizon, but I'm trying to calculate intrinsic value. How do we reconcile these things as investors? Yeah, I mean, calculating intrinsic value until you really dive into it, it seems cleaner maybe in a textbook than it is in real life. And that's because of time horizons, the terminal value problem is another piece of that. So when you build a discounted cash flow model, when an analyst is doing this, they're usually forecasting a company's cash flows over the next five or 10 years. And then they slap terminal value on that, which would essentially represent everything the business will earn after that window. So tweaks to a company's long term growth rate or discount rate that can really change your answer wildly. And that's one of the reasons why intrinsic value is never a single precise number carved in stone. As Matt was noting, you know, you could get a lot of different answers for a single stock from, you know, five very adept analysts. Think of intrinsic value as more of a thoughtful range. It's based on how durable you believe a company's competitive advantage really is. And I would add to that, that the further out you look when you're trying to calculate intrinsic value, the less accurate your calculation is going to get. You know, forecasting year 15 of a company's cash flow, is like predicting what you're going to be doing 15 years from now. Like, who knows? You know, the further out your forecast is based, you know, so this is why I don't like the terminal value and things like that when I'm doing discounted cash flow models, because especially if your terminal value starts at year 10 or something like that, it's, you know, it's your own assumptions that The path to the next 10 years are not going to be a straight one. So I tend to rely more on near-term calculations for intrinsic value and asset valuations. Net asset value is a big concept that I use. But the further out you look, the less accurate your numbers are going to be. So just know that going in. Yeah, and I don't think we talk about it enough, but humility is such an important trait in investment. Yeah, and I think one of those things that we just don't talk about enough in investing is this concept of humility. You know, you want to have a degree of confidence when you buy a stock, but at the same time, you have to balance that with the humility because there are a lot of unknowns. And if you don't recognize those things, you're going to have a really hard time as an investor. So this is all great. And listeners, we're going to keep driving this home with a question from the mailbag here in the next segment. You're listening to Motley Fool, Hidden Gems Investor. Bye. Welcome back to Motley Fool Hidden Gems Investing. So we're going to take a question from our mailbag here from John in Denver. I'm going to shorten it a little bit. Basically, it's framed as how the Motley Fool investing philosophy is that you have a five-year, at least, time horizon when you buy a stock. John asks here, I had a couple of stocks, Alster and Twist Bioscience, that took off after I bought them. They came back down to earth somewhat, but at some point, their valuation stopped making sense to me. And I think that we can all relate to that a little bit. You buy a stock because you think it's a good valuation, and all of a sudden, it doesn't make... sense anymore. It doesn't look like a good valuation [10:00] anymore. So how do you guys think about companies that have valuations that get out over their skis? Do you trim them or sell a decent size of your position or just ride the wave? would really appreciate Matt's advice if possible. And Matt, I am going to throw it to you here in just a moment, but I just want to touch on the two companies mentioned by John, Alster and This is a stock that traded around two times sales three years ago. It shot up nearly... 20 to almost 20 times sales earlier this year. So that's a 10 times increase in valuation. This is a company selling low cost LIDAR. Twist Bioscience, this one's much faster, traded at about four times sales earlier at the start this year, and then jumped up to 28 times by middle of times increase in just a matter of months. So yes, the valuations ran for these two stocks. And so I appreciate John's question here. First of all, what a great problem to have. I wish my biggest problem in my portfolio was, hey, this stock 10x, what do I do with it now? But on a serious note, for me, it's a case-by-case basis. And I generally think about it through a framework of four questions. So number one, is my investment thesis still intact? Is the stock doing exactly what I want to do? Because I've made the mistake of selling Tesla way too early, even though it was doing exactly what I Valuation by itself is a weak reason to sell. So number one, is your investment thesis intact? Is the company doing exactly what you want to do? Number two, how big is your position? This is normally the deciding factor of whether I trim a position that has gone a little too valuation heavy. it's usually a bigger case in my mind that I would like to trim relative to a stock that makes up, say, 2% of my portfolio. Being able to sleep at night is worth more than... the thought of a little bit more gain. So trimming definitely makes sense if the position's a little too large for comfort. Number three, would I buy the stock if it were at today's price? If I didn't already own it and it was on my radar and it was trading at the price it is now, would I buy shares? That's usually a really good way to determine whether or not you should sell, trim, hold, or buy more. And number four, and this is a consideration that often gets overlooked, 10x in a taxable account, this is something you really need to take into consideration before making a decision to trim even if you say 25% of your position. If the stock's 10x, that could give you a little tax hit that you're not expecting. So those are the four ways I think about it. But that's all to say it's a case by case basis. So hopefully that little framework helps. You know, I appreciate John is a extreme case here of, yes, essentially 10xing in a short amount of time. I've seen investors, though, talk about trimming a position that the evaluation no longer makes sense after maybe a 20% gain or a 30% gain. And I started thinking about what was your calculation of intrinsic value here if a 20% gain lifts it above a valuation that makes sense. concepts together, this thing of intrinsic value, and then the valuation that I'm looking at right now, I don't know if I'm asking that good. I'm just going to trust you to run with it here. No, no, it's a great question. I mean, I think there's a few ways to think about it. When you have a stock that takes off, its valuation feels detached from reality. There's this tension between the price, the business fundamentals. And I think one of the important things to think about is long-term investing, it doesn't mean you're blindly ignoring valuation. It also can mean sometimes that great businesses look expensive on traditional near-term metrics because the market is pricing in years of future growth. So in my mind, the key question to ask when a stock surges that way is not just, you know, has the share price gone up a lot? It's also, has the price outrun my most optimistic, reasonable estimate of what this business can earn five years from now? That is the important question. When evaluation maybe gets over its skis a bit, I think personally, and this has been my approach, trimming a slice can be a sensible risk management approach. I, in these situations, generally avoid dumping a winning position just because the multiple looks rich. I think really transformative companies can have a habit of growing into lofty valuations. They can surprise us to the upside. Now, the exception to that would be if you have a surge in one or two of your stocks and they balloon into an oversized chunk of your portfolio or you're going to lose sleep over that, that can be a time where taking a little profit off the table lets you lock in some gains while also perhaps sleeping better at night. But bottom line for me, if the business is still executing, it's winning. [15:00] customers expanding margins, strengthening its moat, letting the bulk of my shares ride through the volatility is often how you are able to capture a lot of the upside. And I generally only consider a full exit if the business thesis breaks, as Matt noted, or if the valuation reaches such an extreme level that maybe even flawless execution wouldn't justify the stock price in the future. Well, when we come back, we're going to let each of our guests pitch a stock that they value. You're listening to Motley Fool Hidden Gems Investing. Welcome back to Motley Fool Hidden Gems Investing. We want to make you part of the conversation. So if you have a stock or investing question for Matt, Rachel, or myself, you can email us at podcasts at fool.com. We already did a mailbag segment in this episode, but we would love to do future ones. And so if you can have a short question, a foolish one, or remember that we don't give personalized investing advice, you can email us at podcasts.com. With an S at fool.com. podcasts at fool.com. Now here for our final segment here, I asked both Matt and Rachel to give an example of a stock that they feel like is worthy of a hidden gems moniker that also trades below its intrinsic value. And Rachel, you're kind of surprising me here going with Alphabet out of the gate. So I'm going to let you make your case here. Why does Alphabet trade below its intrinsic value? Yeah, well, and fair disclosure, this is a stock I'm a longtime shareholder of as well. So I have skin in the game as well. You know, we've seen shares pull back. They did pull back immediately after their earnings down to the 290s, well off the 52-week high. Right now, Alphabet's trading around 15 to 16 times trailing earnings. But think about this as a business operating at a half a trillion dollar annual revenue run rate. They're growing their top line by about more than 20%, about 25% year over year. So in many ways, the market is pricing Alphabet more like a slow-growing mature utility than one of the dominant technology compounders. And I believe it is at the time of this recording, the cheapest on that trailing basis of the MAG-7. A lot of this comes down to near-term anxiety that we're seeing from investors over heavy AI CapEx. We've obviously seen some temporary free cash flow compression. Alphabet spent over $50 billion They push their free cash flow negative in building out data centers and expanding their cohort of custom TPUs. But you look at the underlying business, you know, the core engines are firing Google Cloud revenue more than doubled. The cloud backlog is at five hundred and sixty one billion dollars. I think even if you take a conservative view on traditional search monetization, you're still getting a dominant digital ad platform. You're getting, you know, YouTube's massive ecosystem, the hyper growth cloud business. So that is my case for Alphabet. I think it's a fantastic business and I do think it is trading a favorable valuation right now. Question mark that investors have about Alphabet when it comes to this conversation is that intrinsic value does consider the future cash flows of the business, right? And so when you look at it spending $200 billion on CapEx this year, potentially $300 billion next year. I mean, it did say that it was going to increase significantly in 2027, so maybe half a trillion dollars in just two years being spent. Intrinsic value assumes not only are we earning that back in future cash flow, but we're earning it back in spades. I think that's one of the concerns that investors have here with that is that will this produce enough cash? I think a lot of the momentum that we will see with the business over these next few years is going to come from the investments that Alphabet is making now. And so I do think you might continue to see, at least for the next few quarters, that compression in terms of free cash flow. But looking ahead over the next five years and beyond, I think we see a really stark reversal there back to the type of growth that investors such as myself have become accustomed to from Alphabet. So that's definitely more my approach there. Matt, we're going to turn to you here with Brookfield. And this is very interesting for this conversation because it is one of the few companies out there that I'm aware of that actually gives its investors its own intrinsic value estimate. Yeah, so a few companies do that. And to be fair, When a company gives you an estimate of its own intrinsic value, remember who's making the estimate. It's the company. They're putting it in a presentation because they want to make their company look very valuable. Brookfield, we could spend an entire podcast episode just dissecting what Brookfield does. We're not going to do that. But Brookfield, there's three parts of the business. They're a global asset manager. They own roughly 75% of Brookfield Asset Management, BAM, which is also a publicly traded company. They have an insurance business. They have real estate assets. They own... [20:00] Stakes of a bunch of other publicly traded vehicles, Brookfield infrastructure properties, or Brookfield infrastructure, Brookfield... you know, there's five or six of them. But if you've searched Brookfield, you'll find a ton of companies. So there's a lot of different assets that they own. And It's a really complex business, which can be... nice for mispricings. Right now, commercial real estate assets, which are a lot of what they own, are beaten down because of interest rates. Their values are beaten down. So if you look at management's value estimate, which when management does that, like I said, take it with a grain of salt. But it could help make your math a lot easier because they break down line by line where they're getting that estimate from and where they think it's coming from. And you can make your own adjustments and see where they might be a little bit too optimistic. But they estimate share price, their per share value, intrinsic value at roughly $67 per share is And to be fair, their CEO, Bruce Flatt, has a two-decade record. getting the math right. So I tend to give him the benefit of the doubt. The stock is, you know, like I said, his estimate is $67 a share. The stock's roughly $42 a share. So pretty big discount. Excellent growth history. They've compounded at roughly 15% annually for decades. It's a business that I really, really like. And I think demand for alternative assets is going to go nowhere but up with this AI build out. Well, and kids around the country right now are very excited that the intrinsic value estimate is $67 per share. But, you know, Matt, Warren Buffett, he didn't like to give a single number like that. He really liked more of a range because that reflected all of the variables that go into that. Any thoughts here on the precision of this estimate, or maybe you have your own range in there as well? Yeah, and that's a fantastic question because their estimate is based on management's target for their annual growth rate, management's target for management's expectations for interest rates and things like that. This gets back to what I was saying in the intrinsic value discussion, where as an individual investor, you can make a base case, a bear case, a bull case. What would it do to their intrinsic value if, say, interest rates dropped to, you know, 2% or 3% in the next couple of years on the 10-year treasury. That would be a totally different intrinsic value calculation than if you assume that the Fed's going to hike rates two more times and you're going to have an interest rate of 8% on the 10-year in the next couple of years. So that's just one example of the variables that will go into this, but you can make your own bull case, your bear case. And from that, you can get a range of what you think the intrinsic value is. And the real question you need to be asking yourself is, what is this worth today if things had a great intrinsic value estimate, which honestly, theirs isn't like an outrageous bull case. Theirs would be what I would call kind of more toward a middle or a base case. But having the bull and bear case really can help you form a range and know what you're paying for these assets if things don't work out perfectly. Well, thank you, Matt, for breaking that down for us. As always, people on the program may have interest in the stocks they talk about, and The Motley Fool may have formal recommendations for or against. So don't buy or sell stocks based solely on what All personal finance content follows Motley Fool editorial standards and is not approved by advertisers. Advertisements are sponsored content and provided for informational purposes only. To see our full advertising disclosure, please check out our show notes. Thanks to our producer, Dan Boyd, and the rest of the Motley Fool team. For Matt, Rachel, and myself, thank you so much for listening to our show today, and we will see you again on the next episode.